Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Mar 26, 2025 (2 years ago)

Unisom

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA Recommended Intake Limit

Cause type: Nitrosamine impurity

Trace nitrosamine impurities such as NDMA, NDEA or NMBA found above the acceptable daily limit. Nitrosamines are probable human carcinogens that can form during manufacturing or storage. This is the cause behind the large valsartan, losartan and ranitidine (Zantac) recalls. All nitrosamine impurity recalls.

What was recalled

Unisom, SleepMinis, Diphenhydramine HCl, Mini-Capsules, 25 mg, 60 Mini-Capsules bottles, Dist. by Chattem, Inc., P.O. Box 2219, Chattanooga, TN 37409-0219, USA, UPC 0 41167 00670 2

Drug: Diphenhydramine Category: Allergy & Cold Medication

Recalling firm
Chattem Inc
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0362-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Diphenhydramine recalls

See all
Class II · Moderate risk

Unisom

CGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the daily acceptable intake limit defined by the Food and Drug Administration.

Ongoing Nitrosamine impurity Chattem Inc D-0266-2025
Class III · Low risk

Diphenhydramine HCl 50 mg

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Ongoing Labeling / mix-up Akron Pharma, Inc. NDC 71399-8026-02 D-0199-2025
Class III · Low risk

Diphenhydramine HCl 25 mg

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Ongoing Labeling / mix-up Akron Pharma, Inc. NDC 71399-8028-2 D-0198-2025
Class III · Low risk

Diphenhydramine HCl 25 mg

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Ongoing Labeling / mix-up Akron Pharma, Inc. NDC 71399-8028-1 D-0197-2025

Other recalls by Chattem Inc

All 2025 recalls
Class II · Moderate risk

Unisom

CGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the daily acceptable intake limit defined by the Food and Drug Administration.

Ongoing Nitrosamine impurity Chattem Inc D-0266-2025